Testing effectiveness (Phase 2)UnknownNCT00002589What this trial is testingLymphocyte Therapy in Treating Patients With Kidney CancerWho this might be right forKidney Cancer National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT01688973What this trial is testingTivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by SurgeryWho this might be right forRecurrent Renal Cell CarcinomaStage III Renal Cell CancerStage IV Renal Cell Cancer+2 more National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00019539What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced Kidney CancerWho this might be right forStage IV Renal Cell CancerRecurrent Renal Cell Cancer National Cancer Institute (NCI)
Not applicableStudy completedNCT02526511What this trial is testingPerfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney TumorsWho this might be right forStage I Renal Cell CancerStage II Renal Cell CancerStage III Renal Cell Cancer+1 more Rutgers, The State University of New Jersey 75
Testing effectiveness (Phase 2)Study completedNCT00354250What this trial is testingIspinesib in Treating Patients With Metastatic or Unresectable Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00020540What this trial is testingBiological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01141569What this trial is testingRO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) TherapyWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00004880What this trial is testingVaccine Therapy in Treating Patients With Advanced Kidney CancerWho this might be right forKidney Cancer Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00316901What this trial is testingPositron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical TrialWho this might be right forKidney CancerMelanoma (Skin) National Institutes of Health Clinical Center (CC) 70
Large-scale testing (Phase 3)Study completedNCT00087022What this trial is testingMonoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney CancerWho this might be right forKidney Cancer Heidelberg Pharma AG 864
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT00303862What this trial is testingAZD2171 in Treating Patients With Refractory Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Ended earlyNCT00090870What this trial is testingPEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Medical University of South Carolina 10
Testing effectiveness (Phase 2)Study completedNCT01024205What this trial is testingSunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney CancerWho this might be right forKidney Cancer Barts and the London School of Medicine and Dentistry 43
Not applicableStudy completedNCT04501913What this trial is testingRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesWho this might be right forClinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+169 more City of Hope Medical Center 22
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)WithdrawnNCT00489710What this trial is testingTalabostat in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer University of Nebraska
Testing effectiveness (Phase 2)UnknownNCT00003181What this trial is testingInterleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Hope Cancer Institute, Inc. 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05411081What this trial is testingTesting Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 TrialWho this might be right forMetastatic Papillary Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 National Cancer Institute (NCI) 200